{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02474914","recordId":"NCT02474914","peptideSlug":"octreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02474914-octreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02474914.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02474914.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"octreotide","submittedDate":"2015-06-17","publishedAt":"2026-08-23","recordId":"NCT02474914","recordSha256":"727fe0d6c785516bf8e7117146f327b024934e6f76afea15510528df25157ced","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02474914?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"octreotide","submittedDate":"2017-04-03","publishedAt":"2026-08-23","recordId":"NCT02474914","recordSha256":"4bdeaa7a407a6d99059fa897b9de4414fb47860d7a5bef9e2a42db46b9acf0c7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02474914?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"octreotide","submittedDate":"2017-05-19","publishedAt":"2026-08-23","recordId":"NCT02474914","recordSha256":"7f4ff4981c69d467b86b3326646d118768279533cd7092c50da6631cf18b676c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02474914?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Description","Study Design","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-08-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"octreotide","submittedDate":"2017-08-18","publishedAt":"2026-08-23","recordId":"NCT02474914","recordSha256":"1dfe33d396c199e81807cb18670e06810ffa2e9e5d4dda49f576fc04ff69d525","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02474914?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"5046aafa13e330f8994760571c2c4d25c0adcf1ed0d7d70c6a6450bf3f10275f"}}